Chronic headaches/migraines: extending indications for breast reduction
Abstract
BACKGROUND: In patients with macromastia, the currently accepted indications for reduction mammaplasty are back pain, neck pain, shoulder grooving, and intertrigo in the inframammary fold. Occipital neuralgia and chronic headaches/migraines are not indications, but the authors noted anecdotally that numerous patients with macromastia complained of chronic headaches/migraines, and many of them reported headache improvement following surgery. Therefore, the authors conducted a retrospective review of their cases to evaluate this association.
METHODS: A retrospective chart review of all patients undergoing reduction mammaplasty between 2003 and 2008 performed by the senior author (I.D.) was conducted. Patients were followed with clinic visits and telephone interviews. Collected data included preoperative symptoms, pain scores, and postoperative findings. Statistical analysis was conducted using the paired t test.
RESULTS: Of the 84 patients who underwent reduction mammaplasty for macromastia between 2003 and 2008, 58 (69 percent) had chronic headaches preoperatively. Of these 58 patients, 31 (53 percent) reported a greater than 50 percent reduction in headache frequency and severity, with 12 (21 percent) stating that their headaches resolved completely after surgery. These patients reported a mean pain score of 7.2 (of 10) before surgery that dropped to 3.2 after reduction mammaplasty. Of all patients, 90 percent reported an improvement in their quality of life.
CONCLUSIONS:…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 84 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.